Dow Up 0.19% Nasdaq Up 0.56%

AbbVie Inc. (ABBV)

-NYSE
65.19 Down 0.31(0.47%) 4:00PM EST
|After Hours : 65.14 Down 0.05 (0.08%) 4:19PM EST
Prev Close:65.50
Open:65.04
Bid:35.00 x 100
Ask:65.47 x 100
1y Target Est:66.86
Beta:1.928
Earnings Date:Jan 29 - Feb 2 (Est.)
Day's Range:64.93 - 65.68
52wk Range:45.50 - 66.24
Volume:4,975,545
Avg Vol (3m):13,193,600
Market Cap:103.86B
P/E (ttm):28.34
EPS (ttm):2.30
Div & Yield:1.96 (3.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ABBV

Comparison

Symbol% ChgMkt Cap
ABBVDown 0.47%103.86B
MRKDown 0.44%169.28B
NVSDown 0.48%230.43B
PFE 0.00%191.79B

Key Statistics

Forward P/E (1 yr):15.45
P/S (ttm):5.32
Ex-Dividend Date:13-Jan-15

Analysts

Annual EPS Est (Dec-14) :3.31
Quarterly EPS Est (Dec-14) :0.86
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.57

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback